Protein Design and Engineering Market, 2021-2035
To order
this detailed 280+ page report, please visit https://www.rootsanalysis.com/reports/protein-design-and-engineering-market.html
Key Inclusions
§
A detailed review of
the overall landscape of companies offering protein design and engineering services to various
organizations, including pharma / biotech firms, CROs and research / academic
institutes, along with analysis based on various relevant parameters, such as
year of establishment, company size (in terms of employee count) and location
of headquarters. The chapter also provides details related to protein design
and engineering service(s) offered (protein sequencing, protein library
generation, protein screening, protein characterization, protein purification,
de-novo protein synthesis and in-silico analysis), additional services offered (protein
expression, drug discovery, protein-protein interaction analysis, protein
identification, bio imaging of proteins, protein extraction and biological
pathway identification), type of protein engineering approach used (directed
evolution, rational designing and semi- rational designing), type of protein
(antibodies, enzymes, peptides, vaccines and others), type of application
(therapeutics and diagnostics) and type of protein expression (cell surface and
cell free).
§
A competitiveness
analysis of protein design and engineering service providers, segmented into
three categories, namely small (1-50 employees), mid-sized (51-500 employees),
and large companies (>500 employees). Within the peer group, companies were
ranked based on various relevant parameters, such as supplier power (based on
the experience) and company competitiveness (based on parameters, such as
number of protein design and engineering services offered, type of technique
used, type of protein engineering approach used, number of additional services
offered, application areas and type of protein expression).
§
Elaborate profiles of
key players that are engaged in offering services for protein design and
engineering. Each profile features a brief overview of the company (including
information on year of establishment, number of employees, location of
headquarters and key executives), financial information (if available),
information on services offered, recent developments and an informed future
outlook.
§
A detailed assessment
of the current market landscape of protein design and engineering technology
providers, featuring analysis based on several parameters, such as year of
establishment, company size (in terms of employee count) and location of
headquarters. In addition, the chapter highlights an in-depth analysis of
various protein design and engineering technologies based on type of protein
design and engineering service(s) supported (protein sequencing, protein
library generation, protein screening, protein characterization, de novo protein
synthesis and in-silico analysis), additional services supported (drug
discovery, protein-protein interaction analysis and protein expression), type
of protein engineering approach used (rational designing, directed evolution
and semi-rational designing), type of protein (proteins / peptides, antibodies,
enzymes, cytokines and viruses) and type of application (therapeutics and
diagnostics).
§
An insightful 2×2
matrix representation of the competitiveness analysis of various protein design
and engineering technologies segregated into two peer groups based on the
company size of their respective technology provider, namely small (1-50
employees) and mid-sized companies (51-500 employees). Within the peer group,
technologies were ranked based on various relevant parameters, such as supplier
power (based on the experience of the technology provider) and technology
competitiveness (based on parameters,
including number of protein design and engineering services supported, number
of additional services supported, type of protein and type of application).
§
Elaborate profiles of
key players that are engaged in offering technologies for protein design and
engineering. Each profile features a brief overview of the company (including
information on year of establishment, number of employees, location of
headquarters and key executives), financial information (if available),
information on technology offered, recent developments and an informed future
outlook.
§
An analysis of the
partnerships that have been inked by stakeholders engaged in this domain,
during the period 2017-2021, covering R&D agreements, technology licensing
agreements, product development and commercialization agreements, research
agreements, service alliances, product development agreements, acquisitions /
mergers, technology / software development agreements and other related
agreements.
§
An in-depth analysis
of over 130 protein / peptide based therapy developers that are likely to
partner with protein design and engineering services and technology providers,
based on several relevant parameters, such as developer strength (based on
company size and its experience), pipeline strength (based on the number of
drugs in pipeline and their stage of development and therapeutic area).
§
An in-depth analysis
of over 550 patents filed / granted related to protein design and engineering,
till 2021. The instances have been analyzed based on various relevant
parameters, such as type of patent, application year, publication year,
regional applicability, CPC symbols, emerging focus areas, type of applicant,
leading patent assignees (in terms of number of patents filed / granted),
patent benchmarking and valuation.
§
A detailed analysis
of completed, ongoing and planned clinical studies of various protein / peptide
based therapies on relevant parameters, such as trial registration year, trial
phase, trial recruitment status, type of sponsor, target patient segment,
leading industry and non-industry players (in terms of number of registered
trials conducted) and key geographical regions.
§
A case study
presenting the key characteristics of novel peptide therapeutics, along with
information on their applications and advantages, as well as key challenges
associated with their development process.
The report also features the likely distribution
of the current and forecasted opportunity across important market segments,
mentioned below:
§ Type
of Protein Engineering Approach Used
§ Rational
Designing
§ Directed
Evolution
§ Semi
- Rational Designing
§ Type
of Protein
§ Antibodies
§ Peptides
§ Enzymes
§ Vaccines
§ Others
§ Type
of Application
§ Therapeutics
§ Diagnostics
§ Type
of End User
§ Pharma
/ Biotech Firms
§ CROs
§ Research
/ Academic Institutes
§ Key
Geographical Regions
- North
America
- Europe
- Asia-Pacific
- Latin
America
- MENA
- Rest of the World
To request a
sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/protein-design-and-engineering-market.html
Key Questions Answered
§
Who are the leading
players offering protein design and engineering services?
§
What is the relative
competitiveness of different protein design and engineering service providers?
§
What are the popular
types of protein design and engineering technologies available in the market?
§
What types of
partnership models are commonly being adopted by stakeholders in this industry?
§
How is the
intellectual property landscape in this field likely to evolve in the foreseen
future?
§
Which are the most
active clinical trial centers?
§
What are the major
market trends and driving factors that are likely to impact the growth of
protein design and engineering market?
§
How is the current
and future market opportunity likely to be distributed across key market
segments?
You may also be
interested in the following titles:
1.
ADC Cytotoxic Payloads /
Warheads Market: Products and Services Market: Industry Trends and Global Forecasts, 2021-2035
2.
Site Management
Organizations (SMO) Market: Industry Trends and Global Forecasts, 2021-2035
3.
Glycosylation Analysis
Services Market:
Industry Trends and Global Forecasts, 2021-2030
4.
Display Library
Technologies and Affiliated Services Market: Industry Trends and Global Forecast,
2021-2030
5.
Peptide Therapeutics
Market:
Industry Trends and Global Forecasts, 2021-2030
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Comments
Post a Comment